弥漫性大B细胞淋巴瘤接受R-CHOP治疗后出现的可逆性后部白质脑病综合征 - Suppr

Suppr

超能文献

Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.

作者信息

Hosoi Masataka, Yamamoto Go, Imai Yoichi, Kurokawa Mineo

出版信息

Ann Hematol. 2010 Feb;89(2):207-8. doi: 10.1007/s00277-009-0783-x. Epub 2009 Jul 7.

DOI:10.1007/s00277-009-0783-x

PMID:19582454

Abstract

摘要

相似文献

Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.

Ann Hematol. 2010 Feb;89(2):207-8. doi: 10.1007/s00277-009-0783-x. Epub 2009 Jul 7.

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.

Rheumatology (Oxford). 2004 Aug;43(8):1050-3. doi: 10.1093/rheumatology/keh248. Epub 2004 Jun 8.

[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].

Ai Zheng. 2005 Dec;24(12):1421-6.

[Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].

Ai Zheng. 2005 Dec;24(12):1498-502.

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

J Clin Oncol. 2005 Jun 20;23(18):4117-26. doi: 10.1200/JCO.2005.09.131. Epub 2005 May 2.

Images in haematology. Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy.

Br J Haematol. 2010 Jul;150(2):129. doi: 10.1111/j.1365-2141.2010.08189.x. Epub 2010 May 11.

Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.

Cancer. 2010 Dec 1;116(23):5432-9. doi: 10.1002/cncr.25509. Epub 2010 Jul 27.

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).

J Clin Oncol. 2005 Mar 20;23(9):1984-92. doi: 10.1200/JCO.2005.08.133. Epub 2005 Jan 24.

CHOP plus rituximab--balancing facts and opinion.

N Engl J Med. 2002 Jan 24;346(4):280-2. doi: 10.1056/NEJM200201243460411.

[Treatment of diffuse large B-cell lymphoma].

Dtsch Med Wochenschr. 2008 Sep;133(36):1785-94; quiz 1795-6. doi: 10.1055/s-0028-1082813. Epub 2008 Sep 2.

引用本文的文献

Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database.

Front Pharmacol. 2025 Feb 18;16:1459067. doi: 10.3389/fphar.2025.1459067. eCollection 2025.

Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report.

BMC Neurol. 2022 Aug 25;22(1):318. doi: 10.1186/s12883-022-02849-1.

Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen.

Cureus. 2022 May 14;14(5):e24988. doi: 10.7759/cureus.24988. eCollection 2022 May.

Acute Respiratory Distress Syndrome and Posterior Reversible Encephalopathy Syndrome following Rituximab Therapy.

Case Rep Nephrol Dial. 2016 Feb 24;6(1):32-9. doi: 10.1159/000444250. eCollection 2016 Jan-Apr.

Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.

Case Rep Neurol Med. 2015;2015:325657. doi: 10.1155/2015/325657. Epub 2015 May 26.

Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Oncologist. 2015 Jul;20(7):806-11. doi: 10.1634/theoncologist.2014-0149. Epub 2015 Jun 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验